Jason Litten

Jason Litten is an accomplished medical executive with extensive experience in the biopharmaceutical industry, currently serving as Chief Medical Officer at Chimeric Therapeutics since July 2022. Prior positions include Chief Medical Officer at Artiva Biotherapeutics and Vice President of Clinical Development at Juno Therapeutics, Inc. and Clovis Oncology. Jason's career began at UT Southwestern Medical Center as a Fellow in Pediatric Hematology/Oncology, following a residency in Pediatrics at the University of Miami. Jason holds a Bachelor of Science in Finance and Economics from Cornell University, an MD from Emory University, and a diploma in Pre-medical Sciences from Harvard University.